Categories: Uncategorized

CDC Announces Shorter Quarantine Guidelines After a COVID-19 Exposure

BY CONNER INSURANCE
During a recent media briefing, the Centers for  Disease Control and Prevention (CDC) announced an  update to quarantine guidelines, offering options for  shorter quarantine periods. The CDC’s updated guidance allows for the following  quarantine periods for those who may have been  exposed to COVID-19 but are without symptoms:
  • Ten-day quarantine period—An individual  may end quarantine 10 days after exposure  if the individual does not take a COVID-19  test.
  • Seven-day quarantine period—An individual  may end quarantine seven days after
exposure if the individual tests negative for  COVID-19. While offering these shorter alternatives, the CDC  still recommends a 14-day quarantine as the safest option. “We can safely reduce the length of  quarantine, accepting that there is a  small residual risk that a person who  is leaving quarantine early could transmit to someone else if they  became infected.” – Dr. John Brooks, COVID-19 response  chief medical officer for the CDC Updated Quarantine Guidelines These updated quarantine guidelines come after the  CDC studied the incubation period for COVID-19. The  agency hopes that this shortened time period will  improve compliance among the general public and  lessen the negative economic impact of extended  quarantine periods. As the COVID-19 pandemic evolves, the CDC  continues to update guidance for preventing the  spread of COVID-19. For more information on the  coronavirus pandemic, contact Conner Insurance  today. 
theconners

Share
Published by
theconners
5 years ago

Recent Posts

How Gene and CAR-T Therapies Are Changing the Cost of Employer Health Plans

How Gene and CAR-T Therapies Are Changing the Cost of Employer Health Plans. Healthcare is…

5 days ago

Storm Damage Insurance in Indiana: What Homeowners Need to Know About Hail, Wind & Flooding

Spring in Indiana means one thing for homeowners: storm season is here. From hail damage and…

6 days ago

The Million-Dollar Prescription: How Orphan Drugs Are Redefining Employer Risk

The Million-Dollar Prescription: How Orphan Drugs Are Redefining Employer Risk. One employee, one prescription, and…

2 weeks ago

The $300,000 Difference: Managing the Cost of Specialty Drugs

The $300,000 Difference: Managing the Cost of Specialty Drugs. It often starts with a diagnosis.…

1 month ago

Pharmacy Benefits Are Changing – Is Your Plan Ready?

Pharmacy Benefits Are Changing – Is Your Plan Ready? Many employer health plans appear financially…

1 month ago

How to Properly Insure Classic Vehicles and Valuable Collectibles

Many people own valuable items without realizing their standard insurance policy may not fully protect them.…

1 month ago